- Home
- TRU vs MEDP Comparison
TRU vs MEDP Comparison
Compare TRU & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRU
- MEDP
- Stock Information
- Founded
- TRU 1968
- MEDP 1992
- Country
- TRU United States
- MEDP United States
- Employees
- TRU N/A
- MEDP N/A
- Industry
- TRU Finance: Consumer Services
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- TRU Finance
- MEDP Health Care
- Exchange
- TRU Nasdaq
- MEDP Nasdaq
- Market Cap
- TRU 16.6B
- MEDP 13.4B
- IPO Year
- TRU 2015
- MEDP 2016
- Fundamental
- Price
- TRU $81.82
- MEDP $582.58
- Analyst Decision
- TRU Buy
- MEDP Hold
- Analyst Count
- TRU 12
- MEDP 11
- Target Price
- TRU $104.45
- MEDP $451.70
- AVG Volume (30 Days)
- TRU 4.1M
- MEDP 388.3K
- Earning Date
- TRU 10-23-2025
- MEDP 10-22-2025
- Dividend Yield
- TRU 0.55%
- MEDP N/A
- EPS Growth
- TRU 87.22
- MEDP 25.36
- EPS
- TRU 2.14
- MEDP 14.32
- Revenue
- TRU $4,441,800,000.00
- MEDP $2,358,373,000.00
- Revenue This Year
- TRU $8.06
- MEDP $19.15
- Revenue Next Year
- TRU $8.36
- MEDP $8.91
- P/E Ratio
- TRU $38.76
- MEDP $40.54
- Revenue Growth
- TRU 8.30
- MEDP 13.88
- 52 Week Low
- TRU $66.38
- MEDP $250.05
- 52 Week High
- TRU $108.12
- MEDP $625.00
- Technical
- Relative Strength Index (RSI)
- TRU 48.24
- MEDP 66.38
- Support Level
- TRU $77.15
- MEDP $571.03
- Resistance Level
- TRU $86.71
- MEDP $614.04
- Average True Range (ATR)
- TRU 2.27
- MEDP 20.72
- MACD
- TRU 0.84
- MEDP 4.19
- Stochastic Oscillator
- TRU 54.34
- MEDP 67.58
About TRU TransUnion
TransUnion is one of the three leading credit bureaus in the United States, providing the consumer information that is the basis for granting credit. The company also provides fraud detection, marketing, and analytical services. TransUnion operates in over 30 countries. About 20%-25% of its revenue comes from international markets.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.